Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Mar 9, 2005

30339_dirs_2005-03-09_c261d914-75de-4028-98ab-80ee9e8af55c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-07

Reporting Person: GAILEY JOHN R (VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-03-07 Common Stock A 2885 Acquired 41483.9822 Direct
2005-03-07 Common Stock A 762.34 $25.5700 Acquired 42246.3222 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-03-07 Stock Option (Right to Buy) $25.5300 A 11000 Acquired 2015-03-09 Common Stock (11000.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 194.0831 Indirect
Common Stock 1658.5400 Indirect

Footnotes

F1: Bonus and incentive shares granted on 3/7/05.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.